Background {#Sec1}
==========

Wolfram syndrome is a rare genetic disease with an estimated prevalence of 1 in 770,000 \[[@CR1]\] caused by mutations in the genes *WFS1* \[[@CR2]\] or, less commonly, *WFS2* \[[@CR3]\]. These mutations disrupt normal endoplasmic reticulum functioning \[[@CR4]\] causing cellular apoptosis in different body tissues \[[@CR5]\]. Hallmarks of Wolfram syndrome include insulin dependent diabetes \[[@CR6]\], diabetes insipidus \[[@CR7]\], loss of visual acuity due to optic nerve atrophy, sensorineural hearing loss \[[@CR8]\] and other neurological complications \[[@CR1], [@CR9]\].

While neurological complications in Wolfram syndrome were traditionally thought to be the result of neurodegenerative processes, appearing at more advanced stages of disease, recent data suggest that some brain abnormalities, including decreased brainstem volume, arise early in the disease, some prior to the development of significant clinical symptoms \[[@CR10]\]. Therefore, Wolfram syndrome presents features of both altered neurodevelopment and neurodegenerative processes \[[@CR11]\].

One important clinical marker and one of the earliest signs of common neurodegenerative diseases such as Alzheimer \[[@CR12], [@CR13]\] and Parkinson disease \[[@CR14], [@CR15]\] is olfactory dysfunction. Although olfactory dysfunction has been associated with Wolfram syndrome in clinical reports \[[@CR16]--[@CR19]\] data from standardized tests measuring sense of smell is very limited. Identification of common smells was assessed in 19 Wolfram syndrome participants from the Wolfram Syndrome Research Clinic in Washington University at St. Louis, MO \[[@CR20], [@CR21]\]. Using the University of Pennsylvania Smell Identification Test (UPSIT), we previously reported that 72% of patients with Wolfram syndrome had olfactory defects \[[@CR20]\]. However, because UPSIT measures only how well an individual can identify odorants, it is unknown whether the Wolfram syndrome group's UPSIT performance is secondary to impairments in the peripheral nervous system (smell sensitivity), solely due to impairment at the central level (smell identification), or a combination of both \[[@CR22]\].

Wolfram syndrome is known to affect most senses (vision, hearing, smell). However, we do not know if taste is affected, independent of olfaction. The first neural relay for the central gustatory pathway is in the brainstem, a region severely affected in Wolfram syndrome, thus it is plausible that taste could be affected. Remarkably, unlike the other senses, which carry information to the brain by one single cranial nerve, taste sensations are conveyed by three cranial nerves (facial, glossopharyngeal and vagal). The facial nerve innervates the anterior two-thirds of the tongue; however, a blunted or altered taste sensation mediated by this nerve may be unnoticed when evaluating taste perception in the whole mouth due to central release of inhibition from other oral sensory cranial nerves. The regional application of taste at the tip of the tongue isolates taste perception that is carried by the facial nerve and therefore, the comparison of taste perception in the whole mouth versus that in the tip of the tongue allows detection of specific nerve damage. Defining the nature of taste and smell deficits in Wolfram syndrome would expand our understanding of the specific or global nature of sensory deficits in this complex disorder and could provide biomarkers to evaluate disease progression as well as effectiveness of potential treatments.

The primary goals of the present study were to test the hypotheses that Wolfram syndrome was associated with smell and taste dysfunction. Accordingly, we evaluated smell and taste function using validated psychophysical tests that included regional and whole mouth procedures for taste perception, as well as measures of both smell sensitivity and smell identification in patients with Wolfram syndrome and in two age and sex equivalent healthy (HC) and type 1 diabetes (T1D) control groups.

Methods {#Sec2}
=======

Participants and study design {#Sec3}
-----------------------------

Participants with genetically confirmed diagnosis of Wolfram syndrome were recruited via self or physician referral to attend the annual Washington University Wolfram syndrome Research Clinic. In addition, two control groups were recruited: a healthy control group (HC) and a type 1 diabetes group (T1D). Participants with Wolfram syndrome attended the Wolfram Research Clinic between 2010 and 2017 and participants in the control groups were recruited throughout the years 2013 and 2016. Several participants from the three study groups completed testing procedures in consecutive years, but only data from each participant's initial evaluation of both UPSIT and Sniffin Stick was included in this cross-sectional sample. The three study groups (Wolfram, HC, and T1D) underwent the same psychophysical assessments of smell and taste, described in detail below. In addition to completing taste and smell assessments, participants with Wolfram syndrome were evaluated with a comprehensive battery of test across multiple domains. The Human Research Protection Office at Washington University in St. Louis approved the study protocol. Participants under 18 years of age gave informed assent and their parents or legal guardians gave informed written consent, and those who were 18 years old or older gave informed written consent.

Smell function {#Sec4}
--------------

### Olfactory sensitivity {#Sec5}

Olfactory detection threshold measures the lowest concentration of a smell that can be detected. Olfactory detection thresholds were measured for n-butanol (CAS\# 71--36-3) using previously described and validated methods \[[@CR23]\]. This procedure involved exposing participants to randomized series of three felt-tip pens ("Sniffin' Sticks") in which one had a determined concentration of n-butanol dissolved in deionized water and the other two had deionized water only (i.e. blanks). Participants were blindfolded to prevent visual identification of the blank sticks. On each trial, the uncapped pen tip was exposed for approximately 3 s at two centimeters from the participant's nose. The participant was instructed to sniff in and determine which of the sticks had an odor. Presentation of the triplets occurred approximately every 30 s. Overall, there were 16 n-butanol concentrations (16 successive dilutions with a 1:2 ratio; highest concentration was 4% v/v). A simple staircase method was used so that the concentration in the odor containing stick increased after an incorrect answer and decreased after the participant correctly discerned the stick with the odorant in two consecutive trials. The points at which the concentration sequence changed directions are considered "reversals" of the staircase. Testing continued until the participant achieved seven reversals and the mean of the last four reversals was then calculated as the n-butanol threshold. Based on previous data \[[@CR24]\] an n-butanol threshold dilution level below 10% for their age and sex was considered indicative of hyposmia or abnormal smell functionality.

### Olfactory identification {#Sec6}

Participants completed the 40-item UPSIT \[[@CR25]\]. The test contains four booklets, each with 10 pages containing a "scratch and sniff" box with microencapsulated odorants. The task for the participants was to scratch the box and then indicate which of four response alternatives written on the page best matched the perceived smell. When participants had vision limitations, the investigator read in a loud voice the options to the participant immediately after he/she smelled the scratch and sniff box. Standardized UPSIT scores from normative data, adjusted for age and sex, were used to consider a score under the 10th percentile to be indicative of hyposmia or olfactory dysfunction \[[@CR26]\]. To control for cultural differences affecting recognition or exposure to certain odors, we also calculated scores using a subset of 12 odors that are commonly found in every culture around the world and that are validated as a "Cross-Cultural Smell Identification Test (CC-SIT)" \[[@CR27]\]. Data on UPSIT on a subset of subjects included in this manuscript (19 WFS, 24 HC and 25 T1D) has been published \[[@CR20], [@CR21]\].

Taste function {#Sec7}
--------------

### Taste quality and intensity {#Sec8}

We assessed both taste quality and intensity of varying concentrations of sucrose, sodium chloride and quinine hydrochloride using a regional (tip of the tongue) and a whole mouth taste presentation method, as recommended in the NIH Toolbox for Assessment of Neurological and Behavioral Function \[[@CR28]\]. Participants rated the strength of their taste perception on a generalized labeled magnitude scale (gLMS). The gLMS is a measure of perceived intensity with seven anchor labels provided (Strongest of any kind, Very strong, Strong, Moderate, Weak, Barely detectable, No sensation) \[[@CR29], [@CR30]\]. Before using the gLMS scale to assess the taste of solutions, subjects were trained on the use of the scale and asked to rank light intensities in practice trials (i.e. the intensity of light in a candle-lit restaurant, in a well-lit room and of the strongest/brightest light they have ever seen) \[[@CR28]\]. Data on taste intensity includes only participants who were at least 12 years of age at time of testing because the gLMS scale has not been validated for younger ages (Table [1](#Tab1){ref-type="table"}). Table 1Age, sex and number of participants in the Wolfram syndrome group and control groups for each of the completed assessmentsHCT1DWolframAge (years ± SD)n (male/female)Age (years ± SD)n (male/female)Age (years ± SD)n (male/female)Sucrose Preference14.4 ± 5.315/1113.8 ± 4.89/1314.3 ± 5.816/23Taste Intensity17.1 ± 3.711/716.6 ± 4.36/717.5 ± 4.89/19UPSIT14.8 ± 5.315/1414.4 ± 4.710/1515.1 ± 6.017/23Sniffin' Sticks13.9 ± 4.98/1015.1 ± 5.17/1115.2 ± 6.016/23*HC* Healthy control, *T1D* Type 1 Diabetes, *SD* Standard deviation, *UPSIT* University of Pennsylvania Smell Identification Test

We first assessed regional taste function by applying the taste stimulus in a cotton swab soaked with the taste solution in a semicircular motion around the tip of the tongue. Sucrose (90 mm, 350 mm, and 1050 mm), sodium chloride (NaCl) (100 mm, 320 mm, and 1000 mm), and quinine hydrochloride (0.01 mm, 0.03 mm, and 1 mm) were used as the sweet, salty, and bitter stimulus respectively. The order of presentation of solutions was randomized with exception of the highest quinine concentration, which was always presented at the end.

After the regional taste testing, participants sampled the same taste stimuli described above with the whole mouth. Participants were asked to fill their mouths with \~ 10 mL of the taste solutions, swished for approximately 5 s (without swallowing) and then expectorate into a sink. After completing their ratings in the gLMS, participants rinsed twice with deionized water and waited 30 s before tasting the next stimuli.

### Sucrose preferences {#Sec9}

We assessed sucrose preferences by using the Monell forced-choice, paired comparison tracking technique, which is the NIH Toolbox gustatory measure recommended for young children \[[@CR28]\]. Participants were presented with pairs of solutions that differed in sucrose concentration (from 3 to 36% g/v) and preferences were determined as previously described \[[@CR28], [@CR31]\].

Statistical analyses {#Sec10}
--------------------

Separate one-way ANOVAs with group (Wolfram, T1D, and HC) as the between-subjects factor were used to determine whether groups differed in their smell sensitivity (n-butanol thresholds) and their ability to identify odorants (UPSIT and CCSIT scores). Fisher Exact Tests were conducted to detect differences in the frequency of abnormal smell sensitivity (i.e. dilution level for n-butanol detection thresholds or UPSIT scores below 10% of normative data specific for sex and age group). To examine taste sensitivity, separate two-way mixed ANOVAs were conducted for each taste stimuli (sucrose, sodium chloride and quinine hydrochloride) and for each region (tip of the tongue and whole mouth). The mixed ANOVAS included group (Wolfram, T1D, and HC) as the between-subjects factor and the three concentrations of each taste stimuli as the within-subject factor. When ANOVAs revealed significant differences, post hoc Fisher least significant difference analyses were conducted. The criterion for significance in all analyses was set at α = 0.05. All analyses were performed in Statistica v.13.3.

Results {#Sec11}
=======

Olfactory sensitivity {#Sec12}
---------------------

There were no significant differences between groups for n-butanol detection thresholds (Mean ± SEM; HC: 8.4 ± 0.8; T1D: 7.6 ± 0.8 and Wolfram syndrome: 7.3 ± 0.4; F ~(2,\ 72)~ = 0.82, *P* = 0.44) or the percentage of participants in each group whose detection threshold was below the 10th percentile for age and sex matched normative data (*P* \> 0.49; Fig. [1](#Fig1){ref-type="fig"}). Detection thresholds for one participant with Wolfram syndrome and for 18 participants in the control groups (7 in T1D and 11 in HC) were not available due to participants having a stuffy nose the day of testing or due to technical issues. Fig. 1Olfactory function in participants with Wolfram syndrome and in two control groups: healthy controls (HC) and participants with Type 1 Diabetes Mellitus (T1D). **a** Olfactory sensitivity: Cumulative percentage of participants with a normal (in black) or abnormal (in grey) n-butanol detection thresholds (i.e. below 10% of normative data specific for sex and age group). **b** Olfactory identification: Cumulative percentage of participants with a normal (in black) or abnormal (in grey) UPSIT scores (i.e. below 10% of normative scores specific for sex and age group). \**P* \< 0.05 compared to the two control groups

Olfactory identification {#Sec13}
------------------------

The Wolfram group had lower UPSIT scores (F ~(2,\ 91)~ = 9.97, *P* \< 0.001) and CC-SIT scores (F ~(2,\ 90)~ = 3.3, *P* \< 0.05) than the HC and T1D groups (Mean ± SEM, UPSIT scores: HC: 30.1 ± 1.0; T1D: 31.6 ± 1.1 and Wolfram syndrome: 25.1 ± 1.2; CC-SIT scores: HC: 8.6 ± 0.5; T1D: 8.9 ± 0.5 and Wolfram syndrome: 7.3 ± 0.4). Participants with Wolfram syndrome were more likely to have an UPSIT score ≤ 10th percentile for age and sex matched normative data, than those in the HC and T1D groups (*P* \< 0.0001; Fig. [1](#Fig1){ref-type="fig"}). While performance in the UPSIT positively correlated with age in both HC (*r* = 0.41; *P* \< 0.05) and T1D groups (r = 0.62; *P* \< 0.005)), there was no relationship with age in the Wolfram syndrome group (*r* = − 0.03; *P* \> 0.85), suggesting early appearing deficits in smell identification.

Taste intensity {#Sec14}
---------------

Because preliminary data analysis for taste intensity showed no significant differences between the T1D and HC control groups, the two control groups were combined and henceforth referred to as "Combined Control Group". Six participants in the Combined Control Group did not complete the test with quinine and therefore the final sample for both tip of the tongue and whole mouth procedure for bitter intensity is 25.

Tip of the tongue {#Sec15}
-----------------

The Wolfram group perceived less sweetness in the highest sucrose concentration and less saltiness in the highest NaCl concentration than the Combined control group (Group x Concentration for sucrose: F ~(2,114)~ = 4.42; *P* = 0.014; for NaCl: F ~(2,114)~ = 4.44; *P* = 0.014; Fig. [2](#Fig2){ref-type="fig"}a). However, there were no significant differences between groups in bitterness perception for quinine (*P* \> 0.16). Fig. 2Taste function in participants with Wolfram syndrome and in the average of the two control groups without Wolfram syndrome (Combined controls). Perceived sweetness of increasing concentrations of sucrose, saltiness of increasing concentrations of sodium chloride, and bitterness of increasing concentrations of quinine hydrochloride. **a** Taste perception in the tip of the tongue and **b** in the whole mouth. The right axis shows descriptors visualized by participants when using the general labeled magnitude scale (gLMS). The left axis shows numbers corresponding to those descriptors on the scale. These numbers are not seen by subjects, but experimenters receive them from the computer program. Data are mean values ± SEM. \**P* \< 0.05 compared to Combined control group

Whole mouth {#Sec16}
-----------

Taste intensity increased progressively and similarly between groups with an increase in stimulus concentration (sucrose sweetness: *P* \< 0.00001, NaCl saltiness: *P* \< 0.00001 and quinine bitterness: *P* \< 0.00001). There were no interactions between groups and concentration for any of the assessed taste stimuli (all *P* values \> 0.39; Fig. [2](#Fig2){ref-type="fig"}b).

Sucrose preference {#Sec17}
------------------

There were no differences in the preferred sucrose concentration between Wolfram and the Combined Control groups (F ~(1,\ 85)~ = 0.13; *P* = 0.72; mean sucrose preferred by Wolfram = 18.6 ± 1.6 and Combined Control = 17.8 ± 1.4).

Discussion {#Sec18}
==========

There are three main findings of our cross-sectional study. First, the current results confirm that Wolfram syndrome is associated with olfactory dysfunction \[[@CR20]\]. Second, they further clarify that such olfactory impairment is qualitative (i.e. decreased ability for smell identification) and not due to olfactory insensitivity or secondary to having insulin-dependent diabetes. Third, our findings also suggest that, in contrast to the sense of smell (and vision and audition); the sense of taste is overall well conserved in individuals with Wolfram syndrome.

Experiences with certain odors and their names can be culturally specific; therefore, it could be argued that the lower ability to identify odors in the Wolfram syndrome group is due to the fact that many of the participants in this group, unlike those in the control groups, were coming from other countries and other cities in the United States. However, results from the analysis that used a subset of UPSIT items, which comprise the validated Cross-Cultural Smell Identification Test (CC-SIT) were similar to results with the full UPSIT, suggesting the observed differences between groups in the odor identification test were likely associated to Wolfram syndrome and not due to culturally related differences.

The finding that Wolfram syndrome is more related to a qualitative than a quantitative olfactory dysfunction is consistent with findings in patients with neurological conditions and suggest a smell impairment of central origin. For example, patients with focal unilateral excision in the temporal lobe or orbitofrontal cortex \[[@CR32]\] have a marked impairment in olfactory identification but normal smell detection thresholds. Notably, pointing to a critical role of the orbitofrontal cortical region in higher-order olfactory tasks, smell function in patients with frontal-lobe excision sparing the orbital cortex left, or with parietal or central area lesions was unaffected \[[@CR32]\]. Because the orbitofrontal cortex receives indirect projections from temporal regions via the medial dorsal nucleus of the thalamus, Jones-Gotman and Zatorre, hypothesized that smell identification deficits observed after temporal-lobe brain injury might be due to the disruption of these projections to the orbitofrontal region \[[@CR32]\]. Consistent with this hypothesis, data from preclinical models \[[@CR33], [@CR34]\] and patients with thalamic lesions \[[@CR35]\] show impairment in olfactory identification with normal detection. Another brain region that is not traditionally considered part of the olfactory system but that has been associated with olfactory performance is the cerebellum \[[@CR36], [@CR37]\]. Data from a recent study in healthy adults showed an association between reduced cerebellar gray matter volume and reduced odor identification but not odor detection or discrimination \[[@CR37]\]. Moreover, patients with unilateral cerebellar lesions also have impaired olfactory identification with normal detection thresholds \[[@CR36]\]. Interestingly, we have found that, compared with age and sex equivalent controls, patients with Wolfram syndrome had decreased volume in thalamus and cerebellar cortex \[[@CR11]\].

Although our results strongly suggest a smell impairment of central origin, an alternative mechanism, although not mutually exclusive, is that, as shown for aging, a loss of specificity to olfactory stimuli in the peripheral olfactory system could also contribute to a decline in odor identification \[[@CR38]\]. Specifically, in-vitro studies of biopsies of human olfactory sensory neurons revealed that unlike cells from younger donors, which were highly selective in the odors to which they responded, cells from older donors responded to multiple odor stimuli (i.e. were more "broadly tuned"). Future studies in Wolfram patients should assess olfactory discrimination in addition to olfactory identification to better advance our understanding of the olfactory dysfunction observed in this group.

In contrast to the deficits in smell identification, Wolfram patients have mostly intact taste. We observed a blunted response to taste stimuli in the tip of the tongue, but normal taste function when assessed in the whole mouth in Wolfram syndrome. The resilience of gustation in Wolfram syndrome, in comparison to dysfunction in the other senses, is likely due to the remarkable redundancy of the taste system: our most guarded sensory system \[[@CR39]\]. Unlike other sensory modalities, which rely on one cranial nerve, taste signals are transmitted from the taste buds to the brain via three cranial nerves. In addition, not only are taste receptor cells continuously being replaced in the taste buds (every 9 to 15 days), but entire taste buds can be removed and they will fully regenerate \[[@CR40]\]. The population with Wolfram syndrome evaluated in this study is relatively young and possibly has just started to develop a localized taste dysfunction specifically in the tip of the tongue, which is innervated by a branch of the facial nerve that includes the chorda tympani \[[@CR41]\]. However, because there is a central mutual inhibition between the cranial nerves, when signals from the tip of the tongue are blunted, signals from the other regions of the tongue are intensified such that the net result is normal whole-mouth taste perception \[[@CR41]\].

Limitations of the study include its cross-sectional design and possible participation bias. Wolfram patients were recruited who were relatively early in the disease process and could attend the clinic in St. Louis. Thus, participants who were more severely affected by the disease may have been excluded. Another limitation of the study is that due to time availability, olfactory discrimination, a third component that could shed some light on olfactory dysfunction etiology, was not assessed. Longitudinal studies of these participants are needed to better understand olfactory and taste function with disease progression.

Conclusions {#Sec19}
===========

Using an extensive battery of well-validated psychometric tests, we examined smell and taste perception in a relatively young sample of patients with Wolfram syndrome and in control groups. Wolfram was associated with qualitative olfactory dysfunction that was not secondary to olfactory insensitivity or diabetes. In contrast, taste function was overall well-conserved, with the only exception of a regional decreased perception of taste intensity in the anterior tongue. Future longitudinal studies of taste and smell perception in patients with Wolfram syndrome will be important to determine the potential use of the chemical senses as clinical markers of disease progression.
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